Literature DB >> 20572085

Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit.

Marifina Chilet1, Gerardo Aguilar, Isabel Benet, Javier Belda, Nuria Tormo, José Antonio Carbonell, María Angeles Clari, Elisa Costa, David Navarro.   

Abstract

Cytomegalovirus (CMV) reactivation occurs frequently in critically ill patients. The natural course of CMV infection and the interaction between CMV and the adaptive immune system in this setting remain poorly defined. Fifty-three CMV-seropositive patients in a surgical and trauma intensive care unit were included in this study. The CMV DNA load in tracheal aspirates (TA) and plasma (PL) was monitored by qPCR. CMV-specific T-cell immunity was assessed by intracellular cytokine staining. Plasma TNF-alpha levels were determined by ELISA. CMV reactivation occurred in 39.7% of patients (23% had CMV DNA detected only in TA). The analysis of TA allowed an earlier diagnosis in 28% of patients. Clearance of CMV DNAemia preceded that of CMV DNA in TA in some episodes. Peak CMV DNA levels were significantly higher in TA than in PL (P = 0.02). CMV reactivation developed in the presence of CMV-specific T cells. Termination of CMV reactivation was associated with an expansion of functional CMV-specific T cells. Plasma levels of TNF-alpha did not allow for the prediction of the occurrence of CMV reactivation. CMV-specific T-cell immunity is preserved in most critically ill patients experiencing CMV reactivation. Analysis of respiratory specimens is imperative for an optimal monitoring of CMV reactivation in this setting. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20572085     DOI: 10.1002/jmv.21825

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  23 in total

1.  Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.

Authors:  Jonathan Campbell; Joanne Trgovcich; Michelle Kincaid; Peter D Zimmerman; Paul Klenerman; Stuart Sims; Charles H Cook
Journal:  J Leukoc Biol       Date:  2012-06-22       Impact factor: 4.962

Review 2.  Impact of cytomegalovirus load on host response to sepsis.

Authors:  Thomas Marandu; Michael Dombek; Charles H Cook
Journal:  Med Microbiol Immunol       Date:  2019-04-11       Impact factor: 3.402

3.  Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults.

Authors:  Paula Lopez Roa; Joshua A Hill; Katharine A Kirby; Wendy M Leisenring; Meei-Li Huang; Tracy K Santo; Keith R Jerome; Michael Boeckh; Ajit P Limaye
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

4.  The pathogenetic role of CMV in intensive care unit patients: the uncertainity remains.

Authors:  Gerardo Aguilar; David Navarro
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 5.  Known unknowns: how might the persistent herpesvirome shape immunity and aging?

Authors:  Janko Nikolich-Zugich; Felicia Goodrum; Kenneth Knox; Megan J Smithey
Journal:  Curr Opin Immunol       Date:  2017-08-04       Impact factor: 7.486

Review 6.  Resistant pathogens, fungi, and viruses.

Authors:  Christopher A Guidry; Sara A Mansfield; Robert G Sawyer; Charles H Cook
Journal:  Surg Clin North Am       Date:  2014-10-03       Impact factor: 2.741

Review 7.  Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.

Authors:  Charles H Cook; Joanne Trgovcich
Journal:  Antiviral Res       Date:  2011-03-23       Impact factor: 5.970

8.  Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients.

Authors:  Michal Shteinberg; Pninit Shaked-Mishan; Amalia Kinarti; Amir Abramovitch; Anat Amital; Assaf Jacobi; Aharon E Kolup Feldmann; Maayan Shiner; Vladimir Gershtein; Gabriel Weber; Yochai Adir
Journal:  Lung       Date:  2014-09-09       Impact factor: 2.584

9.  Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.

Authors:  Sara Mansfield; Varun Dwivedi; Sara Byrd; Joanne Trgovcich; Marion Griessl; Michael Gutknecht; Charles H Cook
Journal:  J Med Virol       Date:  2016-02-02       Impact factor: 2.327

10.  Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.

Authors:  Juan José Castón; Sara Cantisán; Francisco González-Gasca; Aurora Páez-Vega; Hasania Abdel-Hadi; Soledad Illescas; Gema Alonso; Julián Torre-Cisneros
Journal:  Intensive Care Med       Date:  2015-11-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.